96153 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms; Six-membered rings having the nitrogen atoms in the positions 1 and 4
Sub-classes:PHOSPHATIDYLAMINE COMPOUNDS INCLUDING A PLURALITY OF TERTIARY AMINO GROUP STRUCTURES AND COMPOSITIONS THEREOF
#2BISPHOSPHONATE LIPIDS, LIPID NANOPARTICLE COMPOSITIONS COMPRISING THE SAME, MINERAL TISSUE-ADSORBED COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
#3NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF
#4Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
#5NOVEL GENE DELIVERY AGENTS
#6APT1 and APT2 Inhibitors and Uses Thereof
#7LIPID COMPOUND OR A DERIVATIVE THEREOF AND PHARMACEUTICAL COMPOSITION EMPLOYING THE SAME
#8IP4-4,6 SUBSTITUTED DERIVATIVE COMPOUNDS
#9PHOSPHOLIPID
#10PHOSPHOLIPID
#11Reagents Useful for Synthesizing Rhodamine-Labeled Oligonucleotides
#12SSTR5 ANTAGONISTS
#13METHOD FOR PRODUCING SOLID ELECTROLYTE
#14Process for the synthesis of substituted chloromethyl dialkylphosphates
#15Substituted bicyclic compounds
#16ANTICANCER ACTIVITIES OF A NOVEL FAMILY OF ETHACRYNIC ACID DERIVATIVES
#17Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
#18STRAD-binding agents and uses thereof
#19Dyes for Analysis of Soluble Protein Aggregates or Misfolded Protein Oligomers
#20Biomimetic nanomaterials and uses thereof
#21Methods for 1,4-diazo N-heterocycle synthesis
#22Phosphonamidates that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
#23Fosnetupitant chloride hydrochloride having improved stability
#24Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
#25Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
#26Substituted bicyclic compounds
#27Reagents useful for synthesizing rhodamine-labeled oligonucleotides
#28Stable liquid formulations of cyclophosphamide and its impurities
#29Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
#30Substituted piperaziniums for the treatment of emesis
#31Substituted bicyclic compounds
#32Methods for 1,4-diazo n-heterocycle synthesis
#33Phosphine-based compound and organic electroluminescence device including the same
#34STAT6 inhibitors
#35Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator
#36Substituted bicyclic compounds
#37Process for synthesizing oxidized lactam compounds
#38Activators of glucokinase
#39Substituted piperaziniums for the treatment of emesis
#40Substituted bicyclic compounds
#41Therapeutically active compositions and their methods of use
#42Chemical Compounds
#43Spirocyclic EBI2 modulators
#44Substituted bicyclic compounds
#45Process for synthesizing oxidized lactam compounds
#46Activators of glucokinase
#47Process for synthesizing oxidized lactam compounds
#48NOVEL DXR INHIBITORS FOR ANTIMICROBIAL THERAPY
#49Phosphonic acid compounds as inhibitors of serine proteases
#50Anti-cancer agent
#51Phosphonic acid compounds as inhibitors of serine proteases
#52HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK
#53Phosphorus containing compounds as protein kinase inhibitors
#54Substituted pyrazolylamides useful as glucokinase activators
#55Chemical compounds
#56Phosphonic acid compounds as inhibitors of serine proteases
#57Activators of glucokinase
#58Process for synthesizing oxidized lactam compounds
#59Cyclopentylacrylamide derivative
#60Substituted pyrazolylamide compounds useful as glucokinase activators
#61Phosphonic acid compounds as inhibitors of serine proteases
#62Phosphonic acid compounds as inhibitors of serine proteases
#63Phosphonic acid compounds as inhibitors of serine proteases
#64Phosphine transition metal complex, process for producing same, and anticancer agent
#65AGONISTS OF THE SPHINGOSINE-1 PHOSPHATE RECEPTOR
#66Piperazine compounds with a herbicidal action
#67Phosphonic acid compounds as inhibitors of serine proteases
#68Novel phosphonic acid compounds as inhibitors of serine proteases
#69Novel phosphonic acid compounds as inhibitors of serine proteases
#70Phosphonic acid compounds as inhibitors of serine proteases
#71Novel phosphonic acid compounds as inhibitors of serine proteases
#72Phosphonic acid compounds as inhibitors of serine proteases
#73Novel phosphonic acid compounds as inhibitors of serine proteases
#74Phosphonic acid compounds as inhibitors of serine proteases
#75Novel phosphonic acid compounds as inhibitors of serine proteases
#76ORGANIC ELECTROLUMINESCENT DEVICE
#77Sulfonyl amino cyclic derivatives and use thereof
#78ANTI-INFECTIVE PHOSPHONATE ANALOGS
#79Reagents useful for synthesizing rhodamine-labeled oligonucleotides
#80Sulfonylethyl phosphorodiamidates
#81Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#82Phosphonate and phosphinate pyrazolylamide glucokinase activators
#83Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#84Pyrazine-based tubulin inhibitors
#852, 3-bis(dialkylphosphino)pyrazine derivative, process of producing the same, and metal complex having the same as ligand
#86Substituted picolinamides as MAO-B inhibitors useful for treating obesity
#87Therapeutic phosphonate compounds
#88Carboxamide derivatives and their use as factor Xa inhibitors
#89Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions
#90Noncardiotoxic pharmaceutical compounds
#91Sulfonylethyl phosphorodiamidates
#92Anti-infective phosphonate analogs
#93Alpha-substituted beta-aminoethyl phosphonate derivatives
#94Alpha-substituted arylalkyl phosphonate derivatives
#95Alpha-substituted heteroarylalkyl phosphonate derivatives
#96Prodrugs activated by targeted catalytic proteins
#97Il-6 production inhibitors
#98Aminodiphosphonate apolipoprotein E modulators
#99Process for reacting alkaloids and use of the reaction products in the preparation of medicaments